NO862876D0 - Nye polypeptider med blodkoaguleringshemmende virkning, fremgangsmaate til deres fremstilling resp. utvinning, deres anvendelse og midler som inneholder disse. - Google Patents

Nye polypeptider med blodkoaguleringshemmende virkning, fremgangsmaate til deres fremstilling resp. utvinning, deres anvendelse og midler som inneholder disse.

Info

Publication number
NO862876D0
NO862876D0 NO862876A NO862876A NO862876D0 NO 862876 D0 NO862876 D0 NO 862876D0 NO 862876 A NO862876 A NO 862876A NO 862876 A NO862876 A NO 862876A NO 862876 D0 NO862876 D0 NO 862876D0
Authority
NO
Norway
Prior art keywords
mentals
resp
recovery
procedure
contain
Prior art date
Application number
NO862876A
Other languages
English (en)
Other versions
NO862876L (no
Inventor
Martin Kramer
Dominique Tripier
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19853525428 external-priority patent/DE3525428A1/de
Priority claimed from DE19863601032 external-priority patent/DE3601032A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO862876D0 publication Critical patent/NO862876D0/no
Publication of NO862876L publication Critical patent/NO862876L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/141Feedstock
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/26Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO862876A 1985-07-17 1986-07-16 Nye polypeptider med blodkoaguleringshemmende virkning, fremgangsmaate til deres fremstilling resp. utvinning, deres anvendelse og midler som inneholder disse. NO862876L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853525428 DE3525428A1 (de) 1985-07-17 1985-07-17 Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
DE19863601032 DE3601032A1 (de) 1986-01-16 1986-01-16 Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel

Publications (2)

Publication Number Publication Date
NO862876D0 true NO862876D0 (no) 1986-07-16
NO862876L NO862876L (no) 1987-01-19

Family

ID=25834067

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862876A NO862876L (no) 1985-07-17 1986-07-16 Nye polypeptider med blodkoaguleringshemmende virkning, fremgangsmaate til deres fremstilling resp. utvinning, deres anvendelse og midler som inneholder disse.

Country Status (16)

Country Link
US (1) US4791100A (no)
EP (1) EP0209061B1 (no)
JP (1) JPH0764875B2 (no)
KR (1) KR940000758B1 (no)
AU (1) AU593820B2 (no)
CA (1) CA1340102C (no)
DE (1) DE3689525D1 (no)
DK (1) DK173509B1 (no)
ES (1) ES2000216A6 (no)
FI (1) FI862950A (no)
GR (1) GR861837B (no)
HU (1) HUT41418A (no)
IE (1) IE61569B1 (no)
IL (1) IL79424A (no)
NO (1) NO862876L (no)
PT (1) PT82993B (no)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0168342B1 (de) * 1984-06-14 1991-07-03 Ciba-Geigy Ag Verfahren zur Herstellung von Thrombin-Inhibitoren
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
EP0324712B1 (de) * 1985-04-11 1993-04-07 Hoechst Aktiengesellschaft Hirudin-Derivat
FR2607517B2 (fr) * 1986-12-01 1989-12-22 Transgene Sa Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu
US5236898A (en) * 1987-05-21 1993-08-17 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5192745A (en) * 1987-05-21 1993-03-09 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
US5114921A (en) * 1988-05-27 1992-05-19 The Children's Hospital Of Philadelphia Amphiphilic peptides and use thereof
DE68919848T2 (de) * 1988-05-27 1995-05-04 Philadelphia Children Hospital Amphiphile peptide und deren verwendung.
DE3819079A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Hirudin-derivate mit verzoegerter wirkung
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
ES2052062T3 (es) * 1988-06-11 1994-07-01 Ciba Geigy Ag Nuevos polipeptidos con actividad anticoagulante.
IL86856A0 (en) * 1988-06-24 1988-11-30 Yissum Res Dev Co Bovine xa factor and pharmaceutical compositions containing the same
IL87004A (en) * 1988-07-06 1992-08-18 Technion Res & Dev Foundation Method and apparatus for bioaffinity separation
GB8817160D0 (en) * 1988-07-19 1988-08-24 Ciba Geigy Ag Novel proteins
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
GB8826428D0 (en) * 1988-11-11 1988-12-14 Biopharm Ltd Antithrombin
US4861865A (en) * 1989-01-23 1989-08-29 Washington University Novel antithrombin peptide
US5254535A (en) * 1989-04-17 1993-10-19 The Children's Hospital Of Pennsylvania Composition and treatment with biologically active peptides and antibiotic
US5187155A (en) * 1989-06-23 1993-02-16 Board Of Regents, The University Of Texas System Anticoagulant peptides
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
CA2026377A1 (en) * 1989-10-03 1991-04-04 John L. Krstenansky Radiolabeled anticoagulant peptides
US5190919A (en) * 1989-11-13 1993-03-02 Board Of Regents, The University Of Texas System Antihemostatic factor vii peptides
DE3939801A1 (de) * 1989-12-01 1991-06-06 Basf Ag Neue proteine und ihre herstellung
DE4001238A1 (de) * 1990-01-18 1991-07-25 Basf Ag Verfahren zur anreicherung bzw. reinigung von biomolekuelen
US5459237A (en) * 1990-02-08 1995-10-17 Magainin Pharmaceuticals Inc. Peptide compositions and uses therefor
WO1991012015A1 (en) * 1990-02-08 1991-08-22 Magainin Sciences Inc. Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell
US5792831A (en) * 1990-02-08 1998-08-11 Magainin Pharmaceuticals Inc. Analogues of magainin peptides containing D-amino acids
AU641215B2 (en) * 1990-02-13 1993-09-16 Merrell Dow Pharmaceuticals Inc. Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
US5386009A (en) * 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
EP0533795A4 (en) * 1990-05-14 1993-10-20 Magainin Sciences, Inc. Composition of and treatment with biologically active peptides having d-amino acid residues
FI912873A (fi) * 1990-06-18 1991-12-19 Fujisawa Pharmaceutical Co Ny polypeptidfoerening och foerfarande foer dess framstaellning.
US5208220A (en) * 1990-06-27 1993-05-04 Magainin Pharmaceuticals, Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase
JPH05507718A (ja) * 1990-06-27 1993-11-04 マゲイニン サイエンセズ インコーポレーテッド 生物活性ペプチドおよびdnaギラーゼを阻害する抗生物質よりなる組成物と治療法
US5428009A (en) * 1990-07-16 1995-06-27 Merck & Co., Inc. Lipopeptide derivatives
CA2047527A1 (en) * 1990-07-24 1992-01-25 Christopher Dunwiddie Method for administering a therapeutic anticoagulant
DE4031731A1 (de) * 1990-10-06 1992-04-09 Basf Ag Protein aus hirudo medicinalis
US5369093A (en) * 1991-03-15 1994-11-29 Merck & Co., Inc. Lipopeptide derivatives
US5837808A (en) * 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
US5385884A (en) * 1991-08-27 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
AU2901692A (en) * 1991-10-16 1993-05-21 Children's Hospital Of Philadelphia, The Composition and treatment with biologically active peptides and antibiotic
DE4140381A1 (de) * 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De Neue synthetische isohirudine mit verbesserter stabilitaet
US5783421A (en) * 1993-04-09 1998-07-21 Bio-Technology General Corp. DNA encoding novel polypeptide having Factor Xa inhibitory activity
US5801017A (en) * 1993-04-09 1998-09-01 Bio-Technology General Corp. Production of recombinant factor Xa inhibitor of leech Hirudo medicinalis
GB9309509D0 (en) * 1993-05-07 1993-06-23 Merck Patent Gmbh Thrombin inhibitors
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
DE19529997C1 (de) 1995-08-16 1997-04-10 Hoechst Ag Verfahren zur Inaktivierung von Carboxypeptidase Y in hirudinhaltigen Kulturbrühen
DE19543737A1 (de) * 1995-11-24 1997-05-28 Hoechst Ag Verfahren zur Ultrafiltration von Peptide oder Proteine enthaltender biologischer Matrices
DE19544233A1 (de) 1995-11-28 1997-06-05 Hoechst Ag Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten
DE69625623T2 (de) 1996-01-31 2003-11-06 Sumitomo Bakelite Co. Ltd., Tokio/Tokyo Verfahren zur Herstellung von in Epoxyharz eingekapselter Halbleitervorrichtung
US6699836B2 (en) 1999-04-02 2004-03-02 The Trustees Of Princeton University Vancomycin analogs
AU4054900A (en) 1999-04-02 2000-10-23 Advanced Medicine East, Inc. Desleucyl glycopeptide antibiotics and methods of making same
SG171340A1 (en) * 2008-11-19 2011-07-28 Avantor Performance Mat Inc New chromatographic media based on phenoxy alkyl and alkoxy-or phenoxy-phenyl alkyl ligands
CN102373216B (zh) * 2011-10-28 2013-06-05 元昊 一种含有医用水蛭素基因的重组真核汉逊酵母工程菌株的构建及重组水蛭素的生产工艺
CN113956339B (zh) * 2021-10-28 2023-02-24 中国药科大学 宽体金线蛭抗凝血因子XIa多肽及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
CA1341414C (fr) * 1984-03-27 2002-12-31 Paul Tolstoshev Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
DE3438296A1 (de) * 1984-04-18 1985-11-07 Hoechst Ag, 6230 Frankfurt Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten

Also Published As

Publication number Publication date
JPH0764875B2 (ja) 1995-07-12
EP0209061A3 (en) 1989-03-15
AU6023386A (en) 1987-01-22
EP0209061B1 (de) 1994-01-12
DK173509B1 (da) 2001-01-15
KR940000758B1 (ko) 1994-01-29
CA1340102C (en) 1998-10-27
DK338486D0 (da) 1986-07-16
GR861837B (en) 1986-11-11
EP0209061A2 (de) 1987-01-21
IE861902L (en) 1987-01-17
DK338486A (da) 1987-01-18
FI862950A0 (fi) 1986-07-15
US4791100A (en) 1988-12-13
IE61569B1 (en) 1994-11-16
IL79424A (en) 1992-02-16
AU593820B2 (en) 1990-02-22
JPS6222799A (ja) 1987-01-30
DE3689525D1 (de) 1994-02-24
FI862950A (fi) 1987-01-18
IL79424A0 (en) 1986-10-31
HUT41418A (en) 1987-04-28
KR870001237A (ko) 1987-03-12
PT82993B (pt) 1989-01-30
ES2000216A6 (es) 1988-01-16
PT82993A (de) 1986-08-01
NO862876L (no) 1987-01-19

Similar Documents

Publication Publication Date Title
NO862876D0 (no) Nye polypeptider med blodkoaguleringshemmende virkning, fremgangsmaate til deres fremstilling resp. utvinning, deres anvendelse og midler som inneholder disse.
NO871165D0 (no) 2-azolylmetyl-2-aryl-1,3-dioksolaner og deres salter, fremgangsmaate til deres fremstilling, midler som inneholder de og deres anvendelse.
NO871167L (no) 2-azolylmetyl-2-aryl-1,3-dioksolaner og deres salter, fremgangsmaate til deres fremstilling, midler som inneholder disse og deres anvendelse.
NO862545D0 (no) Vannbasert polymermateriale og fremgangsmaate til fremstilling, samt anvendelse derav.
DK38984A (da) Pyridazinderivater, som i 3-stillingen er substitueret med amino, og som indvirker paa centralnervesystemet, fremgangsmaade til fremstilling heraf og laegemidler med indhold heraf
NO864488L (no) Trykkbetjent sirkulasjonsventil med loesgjoerbar sikring, og fremgangsmaate for betjening av ventilen.
DK19887D0 (da) Peptider med vasorelaxerende, natriuretisk og diuretisk virkning, fremgangsmaade til deres fremstiling, midler indeholdende forbindelserne og deres anvendelse
NO871052D0 (no) 1,1-disubstituerte cyklopropanderivater, fremgangsmaate til deres fremstilling og deres anvendelse.
NO863765L (no) Arylmetylazoler og salter derav samt fremgangsmaate til fremstilling derav.
NO862975L (no) Kvaternaere oksalkylerte polykondensater, fremgangsmaate til deres fremstilling, og deres anvendelse.
NO862976D0 (no) Oksalkylerte polyesteraminer, fremgangsmaate til deres fremstilling og deres anvendelse.
NO892869D0 (no) Heteropolysakkarider, fremgangsmaate for deres fremstilling og anvendelse.
NO863944D0 (no) L-dopa-derivater, fremgangsmaate til deres fremstilling og farmasoeytisk blanding inneholdende disse derivater.
NO900943D0 (no) Kopolymerer, fremgangsmaate for deres fremstilling og anvendelse.
NO822796L (no) Aminoorganoaminosilaner, fremgangsmaate til deres fremstilling og deres anvendelse
NO863256D0 (no) Nye polyesterpolyoler, fremgangsmaate til deres fremstilling og deres anvendelse i isocyanat-polyaddisjonsfremgangsmaaten.
NO884671D0 (no) Nye flourmetoksyfenyldihydropyridiner, fremgangsmaate til deres fremstilling og deres anvendelse i legemidler.
DK581183A (da) 2-azabicyclo(2.2.1)heptan-derivater, fremgangsmaader til deres fremstilling, midler indeholdende disse derivater og deres anvendelse, samt 2-azabicyclo(2.2.1)heptan-derivater som mellemprodukter samt fremgangsmaader til deres fremstilling
NO871166D0 (no) 2-azolylmetyl-2-aryl-1,3-dioksolaner og deres salter, fremgangsmaate til deres fremstilling, midler som inneholder de og deres anvendelse.
NO893756D0 (no) Basiske 4-aryl-dhp-amider, fremgangsmaate til deres fremstilling og deres anvendelse i legemidler.
NO871744D0 (no) Nye benzotiazinonderivater, fremgangsmaate til deres fremstilling, legemidler som inneholder disse og deres anvendelse.
DK247884D0 (da) Substituerede tetrahydrothiopyran-3,5-dion-4-carboxamider,fremgangsmaade til deres fremstilling og deres anvendelse samt mellemprodukter til fremstillingen
NO901758L (no) Reninhemmende dipeptider, fremgangsmaate for deres fremstilling, midler som inneholder disse og deres anvendelse.
NO822534L (no) Oxotienobenzooksepiner, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel
DK513784D0 (da) Iodacetamider, deres fremstilling og anvendelse til skadedyrsbekaempelse